These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3259874)

  • 1. Chemical oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its in vivo metabolism in rat brain and liver.
    Arora PK; Riachi NJ; Harik SI; Sayre LM
    Biochem Biophys Res Commun; 1988 May; 152(3):1339-47. PubMed ID: 3259874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Castagnoli N; Chiba K; Trevor AJ
    Life Sci; 1985 Jan; 36(3):225-30. PubMed ID: 3871243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver.
    Riachi NJ; Harik SI; Kalaria RN; Sayre LM
    J Pharmacol Exp Ther; 1988 Feb; 244(2):443-8. PubMed ID: 3258032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in perfused rat liver: involvement of hepatic aldehyde oxidase as a detoxification enzyme.
    Yoshihara S; Harada K; Ohta S
    Drug Metab Dispos; 2000 May; 28(5):538-43. PubMed ID: 10772632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+.
    Nakamura S; Vincent SR
    Neurosci Lett; 1986 Apr; 65(3):321-5. PubMed ID: 3487052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
    Vyas I; Heikkila RE; Nicklas WJ
    J Neurochem; 1986 May; 46(5):1501-7. PubMed ID: 3485701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase B(MAO-B) is the major catalyst for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation in human brain and other tissues.
    Glover V; Gibb C; Sandler M
    Neurosci Lett; 1986 Feb; 64(2):216-20. PubMed ID: 3083305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a rat pheochromocytoma cell line, PC12h.
    Naoi M; Takahashi T; Nagatsu T
    Life Sci; 1987 Dec; 41(24):2655-61. PubMed ID: 3121966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Peterson LA; Caldera PS; Trevor A; Chiba K; Castagnoli N
    J Med Chem; 1985 Oct; 28(10):1432-6. PubMed ID: 3876442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases.
    Singer TP; Salach JI; Castagnoli N; Trevor A
    Biochem J; 1986 May; 235(3):785-9. PubMed ID: 3489461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative toxicity and antioxidant activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its monoamine oxidase B-generated metabolites in isolated hepatocytes and liver microsomes.
    Ekström G; Di Monte D; Sandy MS; Smith MT
    Arch Biochem Biophys; 1987 May; 255(1):14-8. PubMed ID: 3496045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.
    Chiba K; Trevor A; Castagnoli N
    Biochem Biophys Res Commun; 1984 Apr; 120(2):574-8. PubMed ID: 6428396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B.
    Fritz RR; Abell CW; Patel NT; Gessner W; Brossi A
    FEBS Lett; 1985 Jul; 186(2):224-8. PubMed ID: 3874094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase.
    Corsini GU; Pintus S; Bocchetta A; Piccardi MP; Del Zompo M
    J Pharmacol Exp Ther; 1986 Aug; 238(2):648-52. PubMed ID: 3488394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase B.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    J Neurochem; 1985 Oct; 45(4):1049-54. PubMed ID: 3928814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractions.
    Weissman J; Trevor A; Chiba K; Peterson LA; Caldera P; Castagnoli N; Baillie T
    J Med Chem; 1985 Aug; 28(8):997-1001. PubMed ID: 3874963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain.
    Riachi NJ; LaManna JC; Harik SI
    J Pharmacol Exp Ther; 1989 Jun; 249(3):744-8. PubMed ID: 2786562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Chiba K; Peterson LA; Castagnoli KP; Trevor AJ; Castagnoli N
    Drug Metab Dispos; 1985; 13(3):342-7. PubMed ID: 2861994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations.
    Cashman JR; Ziegler DM
    Mol Pharmacol; 1986 Feb; 29(2):163-7. PubMed ID: 3485239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B.
    Ottoboni S; Caldera P; Trevor A; Castagnoli N
    J Biol Chem; 1989 Aug; 264(23):13684-8. PubMed ID: 2788162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.